ONCURIA Trademark

Trademark Overview

On Friday, August 4, 2017, a trademark application was filed for ONCURIA with the United States Patent and Trademark Office. The USPTO has given the ONCURIA trademark a serial number of 87556308. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Friday, April 5, 2024. This trademark is owned by NONAGEN BIOSCIENCE CORPORATION. The ONCURIA trademark is filed in the Pharmaceutical Products category with the following description:

Medical diagnostic assay for testing of urine to non-invasively detect bladder cancer
oncuria

General Information

Serial Number87556308
Word MarkONCURIA
Filing DateFriday, August 4, 2017
Status701 - SECTION 8 - ACCEPTED
Status DateFriday, April 5, 2024
Registration Number5596848
Registration DateTuesday, October 30, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 2, 2018

Trademark Statements

Goods and ServicesMedical diagnostic assay for testing of urine to non-invasively detect bladder cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 9, 2017
Primary Code005
First Use Anywhere DateMonday, July 10, 2017
First Use In Commerce DateWednesday, August 1, 2018

Trademark Owner History

Party NameNONAGEN BIOSCIENCE CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90010
Party NameNONAGEN BIOSCIENCE CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHonolulu, HI 96814
Party NameNONAGEN BIOSCIENCE CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHonolulu, HI 96814

Trademark Events

Event DateEvent Description
Friday, April 5, 2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, April 5, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, March 25, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 9, 2024TEAS SECTION 8 RECEIVED
Monday, October 30, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 30, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, September 25, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, September 24, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 24, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, August 31, 2018USE AMENDMENT FILED
Monday, September 24, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 31, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 31, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, August 21, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 12, 2018EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, January 31, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 2, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, November 26, 2017ASSIGNED TO LIE
Monday, November 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 13, 2017EXAMINER'S AMENDMENT ENTERED
Monday, November 13, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 13, 2017EXAMINERS AMENDMENT E-MAILED
Monday, November 13, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, November 9, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 9, 2017NON-FINAL ACTION E-MAILED
Thursday, November 9, 2017NON-FINAL ACTION WRITTEN
Tuesday, November 7, 2017ASSIGNED TO EXAMINER
Wednesday, August 9, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 8, 2017NEW APPLICATION ENTERED

Related Keywords

oncuria detect bladder cancer invasively urine diagnostic assay testing medical